M
Earnings Watch Hub
Muffett Investments · Quarterly Equity Scorecards
Active Coverage: 3 Reports · Updated: Aug 2026
Basic Materials · Precious Metals
Coeur Mining, Inc.
Record Inflection: Top-line jumped +126% YoY to $1.1B with $388M in Free Cash Flow driven by full integration of Rainy River & New Afton.
Revenue
$1.10B
+126% YoY
Free Cash Flow
$388M
Record Output
Gold Output
163.5k oz
+51% YoY
Healthcare · Biotechnology
Gilead Sciences
HIV Engine Strength: Revenue up +10.2% YoY to $7.80B driven by HIV sales ($5.7B). Adj. non-GAAP EPS grew +13% to $2.27.
Revenue
$7.80B
+10.2% YoY
Adj. EPS
$2.27
+13% YoY
HIV Revenue
$5.70B
+12% YoY
Healthcare · RNA Interference
Arrowhead Pharma
Pipeline Catalyst: Top-line beat ($75.2M vs $52.7M expected) with doubled REDEMPLO® sales & $215M PRV accelerating sNDA.
Revenue
$75.2M
+43% Beat
Cash Runway
$1.60B
De-risked
PRV Value
$215M
Fast Track